<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=780280282443813&amp;ev=PageView&amp;noscript=1">
search

    Genmab A/S

    verified_userVerify Profile
    Companies » Health Care » Health Care Equipment & Services » Biotechnology

    About Genmab A/S

    Genmab is a publicly traded, international biotechnology company specializing in the creation and development of differentiated antibody therapeutics for the treatment of cancer. Founded in 1999, the company has two approved antibodies, a broad clinical and pre-clinical product pipeline and three proprietary next generation antibody technologies. Source

    At A Glance

    • CAPITAL RAISE STATUS
      Not Currently Raising
    • FILING TYPE
      Public
    • PLATFORM TYPE
      NASDAQ
    • RAISED AMOUNT
      $X,XXX,XXX
    • PRE-MONEY EVAULATION
      $1,100,000,000
    • SIC CODE
      2834
    • NIN CODE
      ####
    • LEADERSHIP
      Jan G. J. van de Winkel, Ph.D.
    • FOUNDED
      1999
    • EMPLOYEES
      251-500
    • SECTOR
      Health Care Equipment & Services
    • SUBSECTOR
      Biotechnology

    Company Tags

    No articles found.

    TAXA Biotechnologies Inc

    TAXA Biotechnologies Inc

    We enable cheaper, faster, and better genetic engineering of plants. We offer our ...

    We enable cheaper, faster, and better genetic e...

    Amount Raised:    $309,807.00
    Fundraising Status:    EC
    Filing Type:    CF
    Jeeva Medical Corp

    Jeeva Medical Corp

    Jeeva Medical Corp is here to disrupt digital healthcare and empower people to tak...

    Jeeva Medical Corp is here to disrupt digital h...

    Fundraising Status:    EC
    Filing Type:    CF
    Eloxx Pharmaceuticals, Inc.

    Eloxx Pharmaceuticals, Inc.

    Eloxx Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company developi...

    Eloxx Pharmaceuticals, Inc. is a clinical-stage...

    Filing Type:    PU
    Agenus Inc.

    Agenus Inc.

    Agenus is an immuno-oncology company designed to deliver innovation with speed for...

    Agenus is an immuno-oncology company designed t...

    Filing Type:    PU
    Akers Biosciences Inc.

    Akers Biosciences Inc.

    Akers Biosciences, Inc. (aka Akers Bio) was founded in 1989, with the objective of...

    Akers Biosciences, Inc. (aka Akers Bio) was fou...

    Filing Type:    PU
    Hancock Jaffe Laboratories, Inc.

    Hancock Jaffe Laboratories, Inc.

    HJLI specializes in developing and manufacturing bioprosthetic medical devices to ...

    HJLI specializes in developing and manufacturin...

    Filing Type:    PU
    IGM Biosciences, Inc.

    IGM Biosciences, Inc.

    Headquartered in Mountain View, California, IGM Biosciences is a biotechnology com...

    Headquartered in Mountain View, California, IGM...

    Filing Type:    PU
    Immunomedics, Inc.

    Immunomedics, Inc.

    Immunomedics is a clinical-stage biopharmaceutical company developing monoclonal a...

    Immunomedics is a clinical-stage biopharmaceuti...

    Filing Type:    PU
    Syndax Pharmaceuticals, Inc.

    Syndax Pharmaceuticals, Inc.

    Syndax Pharmaceuticals, Inc. is a late-stage biopharmaceutical company focused on ...

    Syndax Pharmaceuticals, Inc. is a late-stage bi...

    Filing Type:    PU
    Intellia Therapeutics, Inc.

    Intellia Therapeutics, Inc.

    Intellia Therapeutics is a leading genome editing company focused on developing cu...

    Intellia Therapeutics is a leading genome editi...

    Filing Type:    PU
    Atossa Genetics Inc.

    Atossa Genetics Inc.

    Seattle-based Atossa Genetics (NASDAQ: ATOS) is a clinical-stage biopharmaceutical...

    Seattle-based Atossa Genetics (NASDAQ: ATOS) is...

    Filing Type:    PU
    ©2026 National Investor Network. All Rights Reserved.